Intelligent Bio Solutions Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Cash & Equivalents	9.4	1.54	8.24	12.57	0.43	0.2
Cash & Cash Equivalents	9.4	1.54	8.24	12.57	0.43	0.2
Cash Growth	312.07%	-81.34%	-34.48%	2842.78%	115.86%	-
Receivables	0.43	0.29	1.09	3.15	0	0
Inventory	0.88	0.98	0	0	0	0
Other Current Assets	0.81	1.05	1.54	2.49	1.91	2.13
Total Current Assets	11.52	3.86	10.87	18.21	2.34	2.33
Property, Plant & Equipment	0.93	1.24	0.39	0	0	0
Long-Term Investments	0	0	0	0	0.14	0
Goodwill and Intangibles	4.59	5.26	0	0	0	0
Other Long-Term Assets	0	0	1.09	3.65	0	0
Total Long-Term Assets	5.52	6.49	1.48	3.65	0.14	0
Total Assets	17.04	10.35	12.35	21.86	2.48	2.33
Accounts Payable	2.13	2.61	1.63	1.48	2.56	1.17
Deferred Revenue	2.29	2.34	3.93	5.25	0	0
Current Debt	0.63	0.58	0	0	5.13	5.13
Other Current Liabilities	0.66	0.36	-0.89	-3.05	0	0
Total Current Liabilities	5.71	5.88	4.66	3.68	7.69	6.31
Long-Term Debt	0.3	0.76	0	0	0	0
Other Long-Term Liabilities	0.03	0.02	1.14	3.17	0	0
Total Long-Term Liabilities	0.33	0.78	1.14	3.17	0	0
Total Liabilities	6.04	6.67	5.81	6.85	7.69	6.31
Total Debt	0.93	1.34	0	0	5.13	5.13
Debt Growth	-44.79%	-	-	-	0.05%	-
Retained Earnings	-49.18	-41.81	-31.18	-22.87	-15.83	-12.67
Comprehensive Income	-0.66	-0.58	-0.79	-0.66	-0.36	-0.22
Shareholders' Equity	11.13	3.8	6.62	15.06	-5.19	-3.98
Net Cash / Debt	8.46	0.2	8.24	12.57	-4.71	-4.93
Net Cash / Debt Growth	1334.97%	-97.55%	-34.48%	-	-	-
Net Cash Per Share	4.07	2.41	134.82	289.75	-132.73	-141.25
Working Capital	5.81	-2.02	6.2	14.52	-5.35	-3.98
Book Value Per Share	5.35	45.38	108.42	346.99	-146.26	-113.89

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).